CMPX Operating Cash Flow (Statement)

Compass Therapeutics · Operating Cash Flow (Statement)

CMPX logo

CMPX Operating Cash Flow (Statement)

Latest reported-$13.42M
CMPX Quarterly Cash from Operations (-$7.89K → -$13.42M)
High-resolution chart · PNG

CMPX operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Compass Therapeutics Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
-13,417,000
-17,269,000
-13,254,000
-10,849,000
-11,832,000
-13,208,000
-9,162,000
-11,051,000
-10,754,000
-13,888,000
-12,354,000
-5,922,000
-10,113,000
-12,229,000
-10,641,000
-10,942,000
-4,600,000
-7,942,000
-4,665,000
-3,457,000
-5,939,000
-5,605,000
-6,573,000
-7,169,000
-5,300,000
-7,761,000
-5,591,000
-6,704,000
-8,969
-10,477
-7,894
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.